Seegene Inc Total Liabilities

Latest as of June 2026: ₩226.66 Billion KRW ≈ $153.60 Million USD

Seegene Inc total liabilities. Based on the latest financial reports, Seegene Inc (096530) has total liabilities worth ₩226.66 Billion KRW (≈ $153.60 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Seegene Inc's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Seegene Inc (2012–2025)

Total liabilities of Seegene Inc from 2012 to 2025. This chart illustrates how Seegene Inc's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Seegene Inc to see how much of total assets are deployed in long-term investments.

Seegene Inc Competitors by Total Liabilities

The table below lists competitors of Seegene Inc ranked by their total liabilities.

Company Country Total Liabilities
Cangzhou Mingzhu Plastic Co Ltd
SHE:002108
China CN¥3.33 Billion
Hubei Heyuan Gas Co Ltd
SHE:002971
China CN¥4.69 Billion
Zhejiang Yankon Group Co Ltd
SHG:600261
China CN¥1.65 Billion
Zhejiang Great Shengda Packaging Co Ltd
SHG:603687
China CN¥1.06 Billion
Quanex Building Products
NYSE:NX
USA $1.27 Billion
Latigo Biotherapeutics, Inc. Common Stock
NASDAQ:LTGO
USA $340.84 Million
CHERVON HOLDINGS LTD
F:AZ9
Germany €826.08 Million
Hangjin Technology Co Ltd
SHE:000818
China CN¥4.72 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Seegene Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 096530 total assets.

Liquidity & Leverage Metrics

Seegene Inc Total Liabilities Ratios Explained

Seegene Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 4.62 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Seegene Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Seegene Inc (2012–2025)

The table below shows the annual total liabilities of Seegene Inc from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 ₩219.98 Billion
≈ $149.08 Million
-1.71%
2024-12-31 ₩223.80 Billion
≈ $151.67 Million
+1.24%
2023-12-31 ₩221.05 Billion
≈ $149.80 Million
-9.03%
2022-12-31 ₩243.01 Billion
≈ $164.68 Million
-40.49%
2021-12-31 ₩408.31 Billion
≈ $276.71 Million
-9.11%
2020-12-31 ₩449.26 Billion
≈ $304.46 Million
+940.74%
2019-12-31 ₩43.17 Billion
≈ $29.25 Million
+20.65%
2018-12-31 ₩35.78 Billion
≈ $24.25 Million
-10.10%
2017-12-31 ₩39.80 Billion
≈ $26.97 Million
-39.37%
2016-12-31 ₩65.65 Billion
≈ $44.49 Million
+11.35%
2015-12-31 ₩58.96 Billion
≈ $39.95 Million
+35.17%
2014-12-31 ₩43.62 Billion
≈ $29.56 Million
-2.19%
2013-12-31 ₩44.59 Billion
≈ $30.22 Million
+7.00%
2012-12-31 ₩41.68 Billion
≈ $28.24 Million
--

About Seegene Inc

KQ:096530 Korea Biotechnology
Market Cap
$966.49 Million
₩1.43 Trillion KRW
Market Cap Rank
#8716 Global
#223 in Korea
Share Price
₩31300.00
Change (1 day)
-3.84%
52-Week Range
₩21850.00 - ₩38900.00
All Time High
₩140042.88
About

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection … Read more